Oxycodone 30mg Tapering Protocol
For tapering oxycodone 30mg, a decrease of 10% of the original dose per week is recommended as a reasonable starting point, with individualization based on patient factors and withdrawal symptoms. 1
General Tapering Approach
- Begin with a 10% reduction of the original dose per week (3mg reduction per week for 30mg oxycodone) 1
- For patients who have been on opioids for longer durations (years), slower tapers of 10% per month may be better tolerated 1
- The FDA recommends tapering by 25% to 50% every 2 to 4 days for patients who no longer require therapy 2
Step-by-Step Tapering Schedule for Oxycodone 30mg
Standard Approach (10% weekly reduction):
- Week 1: Reduce to 27mg daily 1
- Week 2: Reduce to 24mg daily 1
- Week 3: Reduce to 21mg daily 1
- Week 4: Reduce to 18mg daily 1
- Week 5: Reduce to 15mg daily 1
- Week 6: Reduce to 12mg daily 1
- Week 7: Reduce to 9mg daily 1
- Week 8: Reduce to 6mg daily 1
- Week 9: Reduce to 3mg daily 1
- Week 10: Discontinue 1
Alternative Approach (for patients requiring faster tapering):
- Reduce by 20-50% per week until reaching the smallest available dose unit 1
- Once the smallest available dose is reached (typically 5mg for oxycodone), increase the interval between doses 1
- Opioids may be stopped when taken less frequently than once a day 1
Managing Withdrawal Symptoms
- Monitor for withdrawal symptoms including drug craving, anxiety, insomnia, abdominal pain, vomiting, diarrhea, diaphoresis, mydriasis, tremor, and tachycardia 1
- Consider α2-adrenergic agonists (clonidine, lofexidine, guanfacine, tizanidine) to reduce sympathetic activity and withdrawal symptoms 1
- Use symptomatic treatments such as NSAIDs or acetaminophen for muscle aches and pain 1
Special Considerations
- Tapers may need to be paused and restarted when the patient is ready 1
- Tapers often need to be slowed once patients reach low dosages 1
- Consider a taper successful as long as the patient is making progress 1
- More rapid tapers might be needed for patient safety in circumstances such as overdose 1
- Avoid ultrarapid detoxification under anesthesia as it is associated with substantial risks, including death 1
Common Pitfalls to Avoid
- Abrupt discontinuation in physically dependent patients can lead to severe withdrawal symptoms 2
- If withdrawal symptoms become severe, return to the previous dose level and taper more slowly 2
- Patients who are not taking opioids (including those diverting all obtained opioids) do not require tapers 1
- Discuss with patients the increased risk for overdose if they return abruptly to a previously prescribed higher dose 1
Monitoring During Tapering
- Collaborate with mental health providers and specialists as needed to optimize nonopioid pain management and provide psychosocial support 1
- Consider offering naloxone for overdose prevention in high-risk patients 1
- If a patient exhibits signs of opioid use disorder, arrange for appropriate treatment 1
The Mayo Clinic approach uses a gradual, structured taper over 3 weeks with completion rates above 90%, though this is typically in a supervised setting 1. For outpatient tapering, the slower approach described above is generally safer and better tolerated 1.